Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Ptcy Versus High Dose of ATG in HLA-Mismatched Unrelated Stem Cell Transplantation for Hematological Malignancies

Jonathan Bordat, Eléonore Kaphan, Marie Robin, Flore Sicre de Fontbrune, Florian Chevillon, Gerard Socie, Alienor Xhaard, Regis Peffault de Latour, David Michonneau

Blood (2024) 144 (Supplement 1): 7343.

https://doi.org/10.1182/blood-2024-208643

Published: 2024

Journal Articles

COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)

Per Ljungman, MD PhD, Rafael De La Camara, MD, Malgorzata Mikulska, Gloria Tridello, Beatriz Aguado, MD, Yves Beguin, MD PhD, Rodrigo Martino Bufarull, Fabio Ciceri, MD, Lucía López Corral, MD, Claudia Crippa, MD, Dries Deeren, MD PhD, Rafael F. Duarte, MD PhD FRCP, María Laura Fox, Anna Grassi, MD, María-José Jimenez, MD, Safiye Koculu, MD, Mi Kwon, MD PhD, Juan Carlos Vallejo Llamas, Jose Luiz Lopez Lorenzo, MD, Stephan Mielke, MD, Javier López Jiménez, MD PhD, Zoraida Mesa Morales, Kim H. Orchard, MBBS,PhDFRCP,FRCPath, Rocio Parody Porras, Victoria Potter, MBBS, BSc, FRACP, FRCPA, María Suárez-Lledó, MD, Nicolaas Schaap, MD PhD, Celestine Simand, MD, Luisa Sisinni, MD, John A Snowden, MD PhD, Daniele Vallisa, MD, Ipek Yonalhindilerden, Alienor Xhaard, MD, Nina Simone Knelange, Angel Cedillo, Nicolaus Kröger, MD, Jose Luis Piñana Sanchez, Jan Styczynski, MD PhD

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-138732

Published: 2020

Journal Articles

Risk Factors for Severe Form of COVID-19 after Allogeneic Hematopoietic Stem Cell Transplantation: A SFGM-TC Multicentre Cohort Study

Alienor Xhaard, MD, Constance Xhaard, Maud D'Aveni, MD, Hélène Salvator, MD PhD, Marie-Laure Chabi-Charvillat, MD, Tereza Coman, MD PhD, Yves Beguin, MD PhD, Yves Chalandon, MD, Xavier Poire, MD, Michael Loschi, MD PhD, Catherine Paillard, MD PhD, Bénédicte Bruno, MD, Patrice Ceballos, MD PhD, Jean-Hugues Dalle, MD PhD, Karin Bilger, MD, Jacques-Olivier Bay, MD PhD, Marie Robin, MD PhD, Stephanie N'guyen-Quoc, MD PhD, Marie Thérèse Rubio, MD PhD

Blood (2020) 136 (Supplement 1): 34.

https://doi.org/10.1182/blood-2020-138411

Published: 2020

Journal Articles

Sexual Life, Fertility and Ovarian Function in Women after Allogeneic Hematopoietic Stem Cell Transplant

Forgeard Nathalie, Matthieu Jestin, Dominique Vexiau, Florian Chevillon, MD, Régis Peffault de Latour, MD PhD, Marie Robin, MD, Flore Sicre de Fontbrune, Alienor Xhaard, David Michonneau, Nicolas Boissel, MD PhD, Catherine Poirot, MD PhD, Nathalie Dhedin, MD

Blood (2019) 134 (Supplement_1): 3301.

https://doi.org/10.1182/blood-2019-127371

Published: 2019

Journal Articles

Evaluation of Graft Versus Host Disease and Relapse Free Survival As Novel Endpoint in Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Joint Naples-Paris Study

Simona Pagliuca, MD, Antonio M Risitano, MD PhD, Sylvie Chevret, Flore Sicre de Fontbrune, MD, Alienor Xhaard, MD, Tereza Coman, MD PhD, David Michonneau, MD PhD, Serena Marotta, MD, Mathilde Ruggiu, Swann Bredin, Regis Peffault de Latour, MD PhD, Gérard Socié, MD PhD, Marie Robin, MD PhD

Blood (2016) 128 (22): 2285.

https://doi.org/10.1182/blood.V128.22.2285.2285

Published: 2016

Journal Articles

Clinical Characteristics, Biological Markers and Comorbidity Indexes As Predictors of Transplant-Related Mortality after Allogeneic Hematopoietic Stem Cell Transplantation: Which One Should We Choose?

Alienor Xhaard, MD, Renato Cunha, MD PhD, Marc Busson, Marie Robin, MD PhD, Nathalie Dhedin, MD, Tereza Coman, MD PhD, Aurelie Cabannes-Hamy, MD, Flore Sicre de Fontbrune, MD, David Michonneau, MD PhD, Gerard Socie, MD PhD, Rodrigo T. Calado, MD PhD, Regis Peffault De Latour, MD PhD

Blood (2016) 128 (22): 3478.

https://doi.org/10.1182/blood.V128.22.3478.3478

Published: 2016

Journal Articles

CD24 hi CD27 + and plasmablast-like regulatory B cells in human chronic graft-versus-host disease

Blood (2015) 125 (11): 1830–1839.

https://doi.org/10.1182/blood-2014-09-599159

Published: 2015

Includes: Supplemental data

Journal Articles

Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab

Régis Peffault de Latour, Véronique Fremeaux-Bacchi, Raphaël Porcher, Aliénor Xhaard, Jérémie Rosain, Diana Cadena Castaneda, Paula Vieira-Martins, Stéphane Roncelin, Paula Rodriguez-Otero, Aurélie Plessier, Flore Sicre de Fontbrune, Sarah Abbes, Marie Robin, Gérard Socié

Blood (2015) 125 (5): 775–783.

https://doi.org/10.1182/blood-2014-03-560540

Published: 2015

Includes: Supplemental data

Journal Articles

Effect of Immune Modulation for Peripheral T-Cell Lymphoma in Response to Relapse after Allogeneic Hematopoietic Stem Cell Transplant: A Study of 63 Patients By the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC).

Blood (2014) 124 (21): 3963.

https://doi.org/10.1182/blood.V124.21.3963.3963

Published: 2014

Journal Articles

Intravenous Once-Daily BuCy 2 With Pharmacokinetic (PK)-Guided Dose Adjustment As Conditioning Regimen For AML Patients In First Complete Remission

Felipe Suarez, MD, Philippe Bourget, PhD, Emilio Paolo Alessandrino, MD, Mario Regazzi, PhD, Gérard Socié, MD, PhD, Mauricette Michallet, MD, PhD, Jérôme Guitton, PHD, Sebastien Wittnebel, MD, Angelo Paci, PHD, Didier Blaise, MD, Bénédicte Devictor, PHD, Ana Berceanu, MD, Véronique Kemmel, PHD, Jorge Sierra, MD, PhD, Maria Estela Moreno Martinez, PHD, Ambroise Marcais, MD, Alexandre Amin, PHD, Anna Amelia Colombo, MD, Francesco Ripamonti, MD, de Latour Régis Peffault, MD, Nathalie Dhedin, MD, Alienor Xhaard, MD, Hélène Labussière-Wallet, MD, Franck E Nicolini, MD, PhD, Marie Y. Detrait, MD, Sophie Ducastelle, MD, Xavier Thomas, MD, Jean-Henri Bourhis, MD, PhD, Gonzalo Ferrini, PHD, Sabine Furst, MD, Bruno Lioure, MD, Rodrigo Martino, MD, PhD, Mireia Riba, PH, Anna Feliu, PHD, Carole Levrault, Marcello Riggi, MD, PhD, Christine Ta Thanh Minh, MD

Blood (2013) 122 (21): 4566.

https://doi.org/10.1182/blood.V122.21.4566.4566

Published: 2013

Journal Articles

Lymphodepletion Followed By Suicide-Gene-Transduced Donor Lymphocyte Infusion: A Strategy To Safely Enhance The Graft-Versus-Tumor Effect

Blood (2013) 122 (21): 153.

https://doi.org/10.1182/blood.V122.21.153.153

Published: 2013

Journal Articles

High Numbers Of Memory T Cells Are Associated With Higher Risk Of Grade II-IV Acute Gvhd After Human Allogeneic Transplantation

Michael Loschi, Régis Peffault de Latour, MD, Raphael Porcher, PhD, Valerie Vanneaux, Marie Robin, MD, PhD, Alienor Xhaard, MD, Jerome Larghero, Gérard Socié, MD, PhD

Blood (2013) 122 (21): 2061.

https://doi.org/10.1182/blood.V122.21.2061.2061

Published: 2013

Journal Articles

Multiparameter single-cell profiling of human CD4 + FOXP3 + regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease

Shen Dong, Sylvie Maiella, Aliénor Xhaard, Yuanyu Pang, Lynn Wenandy, Jérome Larghero, Christophe Becavin, Arndt Benecke, Elisabetta Bianchi, Gérard Socié, Lars Rogge

Blood (2013) 122 (10): 1802–1812.

https://doi.org/10.1182/blood-2013-02-482539

Published: 2013

Includes: Supplemental data

Journal Articles

Localized edema with sclerodermatous evolution: a possible form of skin chronic graft-versus-host disease associated with endothelial activation

Mathilde Tardieu, Michel Rybojad, Régis Peffault de Latour, Marie Robin, Adèle de Masson, Aliénor Xhaard, Hélène Le Buanec, Nathalie Parquet, Flore Sicre de Fontbrune, Anne Bergeron, Catherine Scieux, Valérie Dessirier, Armand Bensussan, Martine Bagot, Gérard Socié, Jean-David Bouaziz

Blood (2013) 122 (3): 463–465.

https://doi.org/10.1182/blood-2013-03-488148

Published: 2013

Journal Articles

Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD

Adèle de Masson, Jean-David Bouaziz, Régis Peffault de Latour, Sebastian Wittnebel, Patricia Ribaud, Marie-Thérèse Rubio, Jean-Baptiste Micol, Felipe Suarez, Stéphanie Nguyen, Jean-Hugues Dalle, Karima Yakouben, Marie Robin, Aliénor Xhaard, Lionel Adès, Jean-Henri Bourhis, Michel Rybojad, Martine Bagot, Gérard Socié

Blood (2012) 120 (25): 5089–5090.

https://doi.org/10.1182/blood-2012-09-453928

Published: 2012

Journal Articles

Influence of Stem Cell Source On GvH and NRM: Comparison of 10/10 HLA-Matched Unrelated Donor (MUD) with 9/10 HLA-Mismatched Unrelated Donor (MMUD) and Unrelated Cord Blood (UCB) Transplants.

Clémence Granier, Emeline Masson, Lucie Biard, Raphael Porcher, PhD, Regis Peffault de la Tour, Marie Robin, Alienor Xhaard, Patricia Ribaud, Pascale Loiseau, Dominique Charron, PhD, Gérard Socié, MD PhD, Nathalie Dhedin, MD

Blood (2012) 120 (21): 3135.

https://doi.org/10.1182/blood.V120.21.3135.3135

Published: 2012

Journal Articles

Anti CMV and/or Anti Adenovirus IFN-g-Positive CD4+ CD8+ T Lymphocytes for Treatment of Viral Infections After Allogeneic HSC Transplantation: First Results

Liliane Dal Cortivo, MD, RITA Creidy, PhD, Aurélie Gabrion, Marianne Leruez-Ville, Sebastien Heritier, MD, Fabien Touzot, MD, PhD, Guilhem Cros, MD, Sebastien Maury, MD, Alienor Xhaard, Marie Ouachee, MD, Ingrid Hamon, Tech, Capucine Picard, MD, PhD, Christophe Cambouris, Salima Hacein Bey Abina, PhD, Stephane Blanche, MD, Marina Cavazzana-Calvo, MD, PhD

Blood (2012) 120 (21): 1906.

https://doi.org/10.1182/blood.V120.21.1906.1906

Published: 2012

Journal Articles

Reconstitution of Regulatory T Cell Subpopulations After Allogeneic Hematopoietic Stem Cell Transplantation and Graft-Versus-Host-Disease

Alienor Xhaard, Helene Moins, Marc Busson, PhD, Maryvonnick Carmagnat, Marie Robin, Patricia Ribaud, Nathalie Dhedin, Sarah Abbes, Antoine Toubert, Gerard Socie, Regis Peffault de Latour

Blood (2012) 120 (21): 1948.

https://doi.org/10.1182/blood.V120.21.1948.1948

Published: 2012

Journal Articles

Donor Characteristics As Pretransplant Predictive Factors of Long-Term Outcomes After Allogeneic Peripheral Blood Stem Cell Transplantation From HLA-Matched Related and Unrelated Donors in Patients with Hematologic Malignancies

Sophie Servais, Raphaël Porcher, Marie Robin, Alienor Xhaard, Emeline Masson, Jerome Larghero, Patricia Ribaud, Sarah Abbes, Nathalie Dhedin, Gerard Socie, Regis Peffault de Latour

Blood (2012) 120 (21): 2000.

https://doi.org/10.1182/blood.V120.21.2000.2000

Published: 2012

Journal Articles

Similar Outcome Between Siblings, Unrelated Donors and Cord Blood After Reduced Intensity Allogeneic Hematopoietic Cell Transplantation for Patients Older Than 50 Years with Acute Myeloid Leukemia in Complete Remission

Regis Peffault de Latour, Claudio G Brunstein, MD, Raphael Porcher, PhD, Patrice Chevallier, MD, PhD, Marie Robin, MD, PhD, Erica D. Warlick, MD, Alienor Xhaard, Celalettin Ustun, MD, Nathalie Dhedin, MD, Mohamad Mohty, MD PhD, Gerard Socie, Daniel J. Weisdorf, MD

Blood (2012) 120 (21): 1985.

https://doi.org/10.1182/blood.V120.21.1985.1985

Published: 2012

NARROW

Ptcy Versus High Dose of ATG in HLA-Mismatched Unrelated Stem Cell Transplantation for Hematological Malignancies

COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH)

Risk Factors for Severe Form of COVID-19 after Allogeneic Hematopoietic Stem Cell Transplantation: A SFGM-TC Multicentre Cohort Study

Sexual Life, Fertility and Ovarian Function in Women after Allogeneic Hematopoietic Stem Cell Transplant

Evaluation of Graft Versus Host Disease and Relapse Free Survival As Novel Endpoint in Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Joint Naples-Paris Study

Clinical Characteristics, Biological Markers and Comorbidity Indexes As Predictors of Transplant-Related Mortality after Allogeneic Hematopoietic Stem Cell Transplantation: Which One Should We Choose?

CD24 hi CD27 + and plasmablast-like regulatory B cells in human chronic graft-versus-host disease

Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab

Effect of Immune Modulation for Peripheral T-Cell Lymphoma in Response to Relapse after Allogeneic Hematopoietic Stem Cell Transplant: A Study of 63 Patients By the French Society of Bone Marrow Transplantation and Cell Therapies (SFGM-TC).

Intravenous Once-Daily BuCy 2 With Pharmacokinetic (PK)-Guided Dose Adjustment As Conditioning Regimen For AML Patients In First Complete Remission

Lymphodepletion Followed By Suicide-Gene-Transduced Donor Lymphocyte Infusion: A Strategy To Safely Enhance The Graft-Versus-Tumor Effect

High Numbers Of Memory T Cells Are Associated With Higher Risk Of Grade II-IV Acute Gvhd After Human Allogeneic Transplantation

Multiparameter single-cell profiling of human CD4 + FOXP3 + regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease

Localized edema with sclerodermatous evolution: a possible form of skin chronic graft-versus-host disease associated with endothelial activation

Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD

Influence of Stem Cell Source On GvH and NRM: Comparison of 10/10 HLA-Matched Unrelated Donor (MUD) with 9/10 HLA-Mismatched Unrelated Donor (MMUD) and Unrelated Cord Blood (UCB) Transplants.

Anti CMV and/or Anti Adenovirus IFN-g-Positive CD4+ CD8+ T Lymphocytes for Treatment of Viral Infections After Allogeneic HSC Transplantation: First Results

Reconstitution of Regulatory T Cell Subpopulations After Allogeneic Hematopoietic Stem Cell Transplantation and Graft-Versus-Host-Disease

Donor Characteristics As Pretransplant Predictive Factors of Long-Term Outcomes After Allogeneic Peripheral Blood Stem Cell Transplantation From HLA-Matched Related and Unrelated Donors in Patients with Hematologic Malignancies

Similar Outcome Between Siblings, Unrelated Donors and Cord Blood After Reduced Intensity Allogeneic Hematopoietic Cell Transplantation for Patients Older Than 50 Years with Acute Myeloid Leukemia in Complete Remission

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only